A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
In addition to Wegovy, incretin mimetics FDA-approved for chronic weight management include Saxenda (liraglutide ... semaglutide medicines (Wegovy, Ozempic, and Rybelsus), patient safety remains ...
The pharmaceutical giant markets the drug as Wegovy for people with obesity, and Ozempic for those with Type 2 diabetes alone or with heart or chronic kidney disease. The ad was a response to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results